Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 24, 2019

SELL
$22.73 - $42.34 $137,289 - $255,733
-6,040 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
$44.35 - $65.71 $2,217 - $3,285
-50 Reduced 0.82%
6,040 $268,000
Q2 2018

Jul 26, 2018

BUY
$42.62 - $73.59 $259,555 - $448,163
6,090 New
6,090 $358,000
Q1 2018

Apr 30, 2018

SELL
$23.52 - $58.17 $553,308 - $1.37 Million
-23,525 Closed
0 $0
Q4 2017

Jan 26, 2018

BUY
$16.95 - $23.48 $398,748 - $552,367
23,525
23,525 $552,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.28B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.